A viscosity-activable nano-micelle with aggregation-induced emission for boosting NIR-II fluorescence imaging-guided synergetic photodynamic/photothermal therapy of breast cancer — Wenwen Cai (2025) | RDL Network
A viscosity-activable nano-micelle with aggregation-induced emission for boosting NIR-II fluorescence imaging-guided synergetic photodynamic/photothermal therapy of breast cancer
Article 2025 en
Authors
WC
Wenwen Cai
JG
Jinyin Ge
JD
Jie Dong
Abstract
1 min read
In view of the fast-growing achievements of cancer phototheranostics, the exploration of advanced materials shows inexhaustible and vigorous vitality. To overcome those limitations of existing materials, such as aggregation-caused fluorescence quenching, inferior selectivity, and high O<sub>2</sub>-dependence, the utilization of specific activatable agents with aggregation-induced emission (AIE) features is highly desirable yet remains challenging. Herein, we have designed an organic small-molecule microenvironment activated AIE agent, namely DPXBI. After encapsulation into amphiphilic DSPE-PEG-RGD through self-assembly, the biocompatibility, water solubility, targeting effect, and circulation time in the blood of obtained nano-micelle <sup>R</sup>M@DPXBI are improved. <sup>R</sup>M@DPXBI showed powerful fluorescence in the second near-infrared (NIR-II) region after being activated by viscosity in the tumor microenvironment, which could accurately identify the boundary of the tumor and determine the optimal accumulation time for following phototherapy. Subsequently, <sup>R</sup>M@DPXBI exerts inhibiting on breast cancer growth through synergistic photodynamic (PDT) and photothermal (PTT) therapy under single laser irradiation. Meanwhile, the phototherapy-induced cellular death increases intracellular viscosity, which further restricts the intramolecular motion of <sup>R</sup>M@DPXBI, resulting in the amplifying of PDT effect. The activated strategy provides a new exploration for the design and development of AIE and viscosity activation agents in tumor theranostics.
Haijun Ma, Yibo An, Yuanyuan Han, Feifan Zhao, Yunfei Zuo, Guokang He, Zhixiang Lu, Ryan T. K. Kwok, Jianwei Sun, Jacky W. Y. Lam, Yen Wei, Ben Zhong Tang
Discussion(0)
No comments yet. Be the first to comment.